Histogen | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Jan 4 00:00 ET
Histogen | DEFA14A: Others
Dec 15, 2023 16:05 ET
Histogen | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Dec 14, 2023 16:25 ET
Histogen | 8-K: Current report
Dec 14, 2023 16:20 ET
Histogen | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Dec 5, 2023 16:15 ET
Histogen | 8-K: Current report
Dec 5, 2023 16:10 ET
Histogen | S-8 POS: S-8 POS
Nov 16, 2023 16:07 ET
Histogen | S-8 POS: S-8 POS
Nov 16, 2023 16:05 ET
Histogen | S-8 POS: S-8 POS
Nov 16, 2023 16:03 ET
Histogen | S-8 POS: S-8 POS
Nov 16, 2023 16:01 ET
Histogen | DEFA14A: Others
Nov 14, 2023 16:05 ET
Histogen: Q3 2023 Earnings Report
Nov 9, 2023 16:25 ET
Histogen | DEF 14A: Definitive information statements
Oct 18, 2023 16:05 ET
Histogen | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Oct 12, 2023 08:16 ET
Histogen | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 4, 2023 16:08 ET
Histogen | 8-K: Current report
Oct 3, 2023 16:05 ET
Histogen | 8-K: Current report
Sep 26, 2023 16:06 ET
Histogen | 8-K: Current report
Sep 18, 2023 16:16 ET
Histogen | 8-K: Current report
Aug 15, 2023 16:05 ET
Histogen | 10-Q: Q2 2023 Earnings Report
Aug 10, 2023 16:26 ET
No Data
No Data